CLOV vs SGMO
Clover Health Investments Corp (CLOV) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
CLOV currently screens at market cap $1.55B. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the CLOV and SGMO stock pages for the full models.
Not investment advice.